Putative extracellular lipoproteins made by group A Streptococcus (GAS) are the focus of this study, which was designed to identify new candidate vaccine antigens. Bioinformatic analysis of a serotype M1 GAS strain identified 30 open-reading frames encoding putative lipoproteins. The genes encoding the mature form of 29 of these proteins were cloned, and 16 recombinant proteins were overexpressed in Escherichia coli and purified to apparent homogeneity. The genes encoding these 16 proteins were highly conserved in GAS strains for which genome sequence data are available (serotypes M1, M3, M5, M12, M18, and M28). Mice inoculated subcutaneously with GAS and humans with GAS pharyngitis and invasive infections seroconverted to most of the 16 recombinant proteins, which indicates that these lipoproteins were produced during infection. The blood of mice actively immunized with 5 of the 16 recombinant proteins had significantly ( ) increased P ! .05 growth-inhibitory activity, compared with the blood of unimmunized mice, which identified these proteins as potential new vaccine candidates.
Group A Streptococcus (GAS) is a major human pathogen that causes suppurative and nonsuppurative infections, including pharyngitis, necrotizing fasciitis, and streptococcal toxic shock syndrome [1] . Necrotizing fasciitis and streptococcal toxic shock syndrome are associated with high morbidity and mortality rates. Suppurative infections and postinfection sequelae, such as acute rheumatic fever, rheumatic heart disease, and glomerulonephritis, result in substantial morbidity and economic loss globally.
No licensed GAS vaccine is available, despite con-siderable efforts made in the last several decades [2] . Many studies designed to develop a GAS vaccine have focused on the variable aminoterminal [3] [4] [5] [6] and conserved carboxyterminal [7] [8] [9] [10] regions of M protein, a major surface protein and virulence factor. GAS strains can be serotyped on the basis of variation in the amino acid sequence of the aminoterminus of M protein, and 1100 different M protein serotypes are known. Anti-M protein antibody made by patients after GAS infection is serotype specific [11, 12] , and immunization of mice with peptides derived from the variable aminoterminal region confers serotype-specific protection [3] .
To develop broader-spectrum M protein aminoterminal region-based vaccines, multivalent M protein vaccines are being developed that use fused recombinant aminoterminal peptides derived from commonly occurring M proteins [4] [5] [6] . Although promising, these multivalent M protein vaccines will not provide immunity against infections caused by strains of all M serotypes because of the variable nature of this protein.
Vaccines based on conserved domains located in the carboxy-terminal region have been reported to evoke protection against strains of heterologous M serotypes but may induce harmful cross-reacting antibodies [13, 14] . Two investigator groups have reported that peptides derived from the conserved C repeats can evoke immunity against mucosal GAS infection [7, 8] . The protective epitope identified did not induce harmful cross-reacting antibodies [8] . In addition, several investigations have provided evidence that immunity to GAS infection may be strain specific rather than M type specific, perhaps because of amino acid variation in the aminoterminus [15, 16] . As a consequence of these and other considerations, non-M protein vaccine candidates have been studied. Relatively recently, several other GAS vaccine candidates have been described (reviewed in reference [2] ), including C5a peptidase [17] , streptococcal pyrogenic exotoxin A [18] , streptococcal pyrogenic exotoxin B [19] , streptococcal pyrogenic exotoxin C [20] , streptococcal protective antigen [21] , fibronectin-binding proteins [22, 23] , R28 protein [24] , and group A carbohydrate [25] . In addition, a streptococcal cellsurface heme-binding protein has been shown to induce production in mice of antibodies with bactericidal activity [26] .
Lipoproteins are a major class of cell surface-exposed proteins in many bacterial pathogens and play critical roles in nutrient uptake, antibiotic resistance, adhesion, protein secretion, and other functions [27] . These molecules have been the target of vaccine research for many pathogenic bacteria. For example, a vaccine against Lyme disease was formulated that was based on outer-surface lipoprotein A of Borrelia burgdorferi [28] . Pizza et al. [29] used the genome sequence of serogroup B Neisseria meningitidis to identify many new vaccine candidates. Three of the 5 conserved candidates that were able to induce antibodies that promote bactericidal activity were lipoproteins [29] . Moreover, many lipoproteins have been shown to provide protective immunity against bacterial pathogens in animal models [30] [31] [32] [33] [34] [35] [36] .
The goal of the present study was to identify new GAS candidate vaccine antigens among putative GAS lipoproteins. Bioinformatic analysis of a serotype M1 GAS genome identified 30 putative extracellular lipoproteins. Sixteen recombinant proteins were purified, and we show that specific antibodies against most of these recombinant proteins were present in serum from experimentally infected mice and from human patients with GAS infection. Five new vaccine candidates were identified using a common bactericidal assay and blood from mice immunized with the recombinant proteins.
METHODS

Subjects and materials.
The serum obtained from mice experimentally infected subcutaneously with GAS strains MGAS5005 and MGAS315 has been described elsewhere [37] . Convalescentphase serum samples were obtained at ∼21 days after diagnosis from 34 patients with streptococcal pharyngitis and from 38 patients with invasive GAS infection. Patients with pharyngitis were found to be infected with organisms of serotypes M1 (3 patients), M2 (3 patients), M3 (1 patient), M4 (3 patients), M6 (1 patient), M12 (4 patients), M28 (4 patients), M73 (1 patient), M75 (7 patients), M77 (5 patients), M89 (1 patient), and M94 (1 patient). Patients with invasive infections were found to be infected with organisms of serotypes M1 (6 patients), M3 (3 patients), M5 (1 patient), M11 (1 patient), M12 (1 patient), M13 (3 patients), M22 (1 patient), M28 (6 patients), M36 (1 patient), M44/61 (2 patients), M58 (2 patients), M75 (2 patients), M89 (2 patients), st833.1 (1 patient), emm122 (1 patient), st2917 (1 patient), emm114 (1 patient), st3757 (1 patient), st6735 (1 patient), and emm102 (1 patient).
Bacterial strains and growth. GAS strain MGAS5005 (serotype M1) was grown in Todd-Hewitt broth (Difco) supplemented with 0.2% yeast extract. Tryptose agar with 5% sheep blood (Becton Dickinson) was used as solid medium. Escherichia coli strains NovaBlue and BL21 (DE3) (both from Novagen) were used for gene cloning and protein expression, respectively.
Gene cloning. Serotype M1 strain MGAS5005 was used as the source strain for DNA encoding the mature form of the target proteins. This strain is genetically representative of most serotype M1 organisms that cause contemporary infections [38] . The primers, vectors, and restriction enzymes used for cloning are listed in table 1. Polymerase chain reaction products were digested with the indicated restriction enzymes and ligated to pET21b (Novagen), pET21d (Novagen), or pET-His2 to obtain recombinant plasmids (table 1). The vector pET-His2 was obtained by inserting the XbaI/EcoRI fragment of pETHis [39] into pET21b linearized by XbaI and EcoRI. Recombinant proteins with the His tag had 12 amino acid residues, MHHHHHHLETMG, fused to the second amino acid residue of each mature protein at the aminoterminus. For production of the mature proteins without the His tag, the first amino acid residue (cysteine) was replaced with a glycine residue. The cloned genes were sequenced to rule out the presence of spurious mutations.
Expression of recombinant proteins. For expression of recombinant proteins lacking the His tag, E. coli BL21 (DE3) cells with plasmids containing the cloned gene of interest were grown overnight at 37ЊC in 6 L of Luria-Bertani broth supplemented with 100 mg/L ampicillin (LBA). For expression of recombinant proteins with the His tag, the gene-containing E. coli BL21 (DE3) bacteria were grown to A 600 ∼1.0 in 4 L of LBA at 37ЊC and induced with 0.5 mmol/L isopropyl b-dthiogalactopyranoside for 6 h. Bacteria were harvested by cen- 
pET-His2/NcoI, EcoRI pLP2007 + NOTE. + and Ϫ indicate that His tag is present or absent, respectively.
trifugation for 10 min to yield a cell paste used for protein purification. Protein purification procedures. The cell paste described above was suspended in 70 mL of 10 mmol/L Tris-HCl (pH 8.0; THCl) and sonicated on ice for 15 min. The samples were centrifuged at 20,000 g for 15 min to remove cell debris, and the lysate, which contained recombinant protein, was collected. All solutions used were buffered with 10 mmol/L THCl. Dialysis was done against 3 L of THCl at 4ЊC for 30 h with 2 buffer changes. Purified proteins were concentrated by (NH 4 ) 2 SO 4 precipitation at 70% of saturation unless indicated otherwise, dialyzed against THCl, and stored at Ϫ20ЊC. All centrifugation was carried out at 20,000 g for 15 min. Ion exchange columns made of DEAE-, Q-, and SP-sepharose were preequilibrated with THCl. Hydrophobic columns made of phenyl sepharose were conditioned with 1.5 mol/L (NH 4 ) 2 SO 4 . The methods of purification of the 5 candidate antigen proteins and the other proteins are described below and in the Appendix.
Spy0385, Spy1245, and Spy1390 proteins that had the His tag were purified according to the manufacturer's protocol, using a column of Ni-NTA agarose (Qiagen). For the purification of Spy1274, the cell lysate was loaded onto a -2.5 ϫ 10 cm SP-sepharose column, the column was washed with 50 mL of THCl, and the protein was eluted with a 150-mL linear gradient of 0-0.5 mol/L NaCl. Fractions containing recombinant Spy1274 were pooled, (NH 4 ) 2 SO 4 (14 g) was added to 65 mL of the pooled material, and the sample was loaded onto a -cm phenyl sepharose column. The protein was eluted 1.5 ϫ 10 with a 200-mL linear gradient of 1.
For the purification of Spy1558, the cell lysate was loaded onto a -cm SP-sepharose column. The column was washed 2.5 ϫ 30 with 80 mL of THCl and eluted with a 200-mL linear gradient of 0-0.2 mol/L NaCl. Fractions containing the protein were pooled. (NH 4 ) 2 SO 4 was added to the pooled material to a concentration of 1.5 mol/L, and the sample was loaded onto a -cm phenyl sepharose column. The column was washed 1.5 ϫ 10 with 40 mL of 1.5 mol/L (NH 4 ) 2 SO 4 and eluted with an 80-mL gradient of 1.5-0 mol/L (NH 4 ) 2 SO 4 . The pooled protein was dialyzed, and column chromatography with a SP-sepharose column was repeated.
Western immunoblot analysis. Purified recombinant proteins were resolved by SDS-PAGE and transferred to nitrocellulose membranes (Schleicher & Schuell) with Towbin transfer buffer, using a Trans-Blot SD semidry transfer cell (Bio-Rad) at 15 V for 40 min. The membrane was blocked with 1:20 Amersham Liquid Block in 150 mmol/L NaCl and 100 mmol/ L Tris-HCl (pH 7.4) for 1 h and incubated for 1 h with mouse serum (1:300 dilution) or human serum (1:2000 dilution) in the block solution. The membrane was rinsed twice and washed 3 times for 15 min each with 0.1% Tween 20 in PBS. The membrane was incubated for 1 h with goat anti-mouse or antihuman IgG (heavy plus light chain) horseradish peroxidaseconjugated secondary antibodies (Bio-Rad) diluted at 1:4000 in the block solution. The membrane was rinsed and washed as described above. Antibody-antigen interaction was visualized by enhanced chemiluminescence.
ELISA. ELISA was used to measure antibody titers of immune serum from mice immunized with recombinant proteins. Ninety-six-well Nunc Maxisorp microtiter plates (Fisher Scientific) were coated at 4ЊC overnight with each purified recombinant protein at a concentration of 0.25 mg/well. The plates were washed 4 times with PBS containing 0.1% (vol/vol) Tween 20 (Sigma; PBS-T). The plates were blocked with 100 mL of 0.1% bovine serum albumin (BSA) in PBS-T for 2 h at room temperature and washed as described above. For the titer determination, the plate was incubated with serum from immunized mice diluted at 1:500 to 1:256,000 in 0.1% BSA in PBS-T at room temperature for 2 h and washed as described above. For assessment of the presence of specific antibodies in immune serum, the plate was incubated with serum from mice who had undergone experimental subcutaneous infection (1:600 dilution) or with patient serum (1:2000 dilution) and washed as described above. The wells were incubated with goat antimouse or anti-human IgG (heavy plus light chain) peroxidase conjugate (1:2000 dilution; Bio-Rad) in 0.1% BSA in PBS-T at room temperature for 2 h. The plates were washed as described above and then washed 4 times with PBS to remove Tween 20. Washing was performed with a SkanWasher 400 microplate washer (Skatron Instruments). The plates were developed with 100 mL of ABTS solution (Roche Molecular Biochemicals) for 45 min, and the absorbance was measured at 405 nm with a SpectraMax 384 Plus microplate spectrophotometer (Molecular Devices). The titer was determined as the reciprocal of serum dilution that was needed to achieve a reading of 1.0 at A 405 .
Bactericidal activity of blood from mice immunized with recombinant proteins. The bactericidal activity of blood from mice immunized with recombinant proteins was assessed by a direct bactericidal activity assay as described elsewhere [26] . In brief, female outbred CD-1 Swiss mice (4-6 weeks old; Charles River Laboratories) were immunized subcutaneously with 50 mg of each recombinant lipoprotein suspended in 200 mL of saline emulsified in 44 mL of monophosphoryl lipid A-synthetic trehalose dicorynomycolate (MPL-TDM) adjuvant (Corixa). Control mice received saline with the adjuvant. Mice received booster injections at weeks 2 and 4 with 50 mg of protein mixed with the adjuvant. Strain MGAS5005 was harvested in exponential phase, washed with sterile PBS, and added to 150 mL of heparinized blood obtained from each control or immunized mouse 5 days after the final boost. The samples were rotated end-overend at 37ЊC for 3 h and plated on tryptose agar containing 5% sheep blood (Becton Dickinson), and colonies were counted.
RESULTS
Identification of open-reading frames (ORFs) encoding putative extracellular lipoproteins.
As assessed by hydrophilicity plot analysis, extracellular GAS proteins have a characteristic pattern at the aminoterminus that includes a hydrophilic region followed by a hydrophobic region, which is caused by the presence of an aminoterminal secretion signal sequence. Analysis of an available genome of a serotype M1 strain [40] identified 123 ORFs encoding proteins with this type of pattern. Thirty-five of the 123 inferred proteins had a cysteine residue after a signal peptide. Thirty of these 35 ORFs were identified as putative lipoproteins (table 2) after exclusion of putative integral membrane-or cell wall-linked proteins (see Discussion). Twenty-nine of these 30 inferred proteins have amino acid sequences that are 196% identical to that of the serotype M1 reference strain SF370, as shown by pairwise comparison of genes found in GAS strains of serotype M1 [40] , M3 [41] , M5 (http://www.sanger.ac.uk/Projects/ S_pyogenes), M12 (authors' unpublished data), M18 [42] , and M28 (authors' unpublished data) (table 2). The spy1306 gene is not present in the M3, M5, and M18 genome sequences. These strains include representatives of opacity factor-negative and opacity factor-positive organisms. Hence, the 29 proteins are highly conserved among these GAS strains.
Recombinant proteins. The genes encoding all putative lipoproteins, excluding spy1306, were cloned from source strain MGAS5005 (serotype M1), and expression of each mature recombinant protein was assessed by SDS-PAGE (data not shown). Some proteins that were not overexpressed as the tag-free form or that could not be easily purified were expressed as fusion proteins containing a His tag. Two proteins were not expressed (Spy0457 and Spy1094), 3 proteins were expressed as insoluble inclusion bodies (Spy0210, Spy0903, and Spy2066), 16 recombinant proteins were successfully overexpressed in soluble form and purified to apparent homogeneity (figure 1), and the other 8 proteins were not purified to apparent homogeneity and, thus, were not characterized. The purified recombinant proteins lacked the secretion signal sequences, and the cysteine residue of the mature form was replaced with a glycine residue. Presence of specific antibodies to recombinant proteins in serum from mice and humans with GAS infection. None of the 16 purified proteins was reactive on Western immunoblot with serum obtained from mice before experimental GAS softtissue infection ( figure 2A) . However, the convalescent-phase serum from these mice was strongly immunoreactive with 7 proteins (Spy0293, Spy0453, Spy1228, Spy1294, Spy1361, Spy1390, and Spy1592) and weakly reactive with 4 proteins (Spy0385, Spy1558, Spy1795, and Spy2000) (figure 2B), which indicates that GAS-infected mice produced specific antibodies against these 11 proteins. Western immunoblot analysis also was performed with serum from human patients with GAS pharyngitis or invasive infection. Seven proteins (Spy0293, Spy0453, Spy1228, Spy1294, Spy1361, Spy1592, and Spy2000) were reactive with all 5 convalescent-phase serum samples tested. The other proteins had immunoreactivity with у1, but not all, of the serum samples tested (data not shown).
Because the Western immunoblot analysis may not detect antibodies directed against native proteins, ELISA was performed to assess the presence of specific antibodies against 5 vaccine candidate antigens (see below) in serum from 10 mice with experimental GAS infection ( figure 2C ) and from patients with pharyngitis (34 patients) or invasive GAS infection (38 patients) (figure 2D). Immunoreactivity was detected against all proteins, except Spy1245, which did not react with serum samples obtained from experimentally infected mice.
Bactericidal activity of blood from immunized mice.
A standard direct bactericidal activity assay was used to test whether mouse immunization with each of these 16 recombinant proteins induced bactericidal antibodies. Mice were immunized 3 times with 50 mg of each recombinant protein mixed with the adjuvant MPL-TDM. The reciprocal specific antibody titers increased from !500 to 15000 for each protein ( figure 3A ). Antibodies against 5 proteins (Spy0385, Spy1245, Spy1274, Spy1390, and Spy1558) significantly inhibited the in vitro growth of serotype M1 strain MGAS5005 ( ; figure 3B) . Antibodies P ! .05 against Spy0293, Spy0453, Spy1795, and Spy2000 also inhibited GAS growth in mouse immune blood by 160%.
DISCUSSION
Putative lipoproteins. Gram-positive bacteria have 3 types of extracellular proteins (freely secreted proteins, lipoproteins, and non-lipoprotein cell-surface proteins), all characterized by an aminoterminal secretion signal sequence with positively charged amino acid residue(s) followed by a hydrophobic region. The distinctive feature of the lipoprotein signal sequences is the presence of a cysteine residue at the end of the hydrophobic region and a protease cleavage site located before the cysteine residue [43] . We identified 30 putative GAS lipoproteins by searching for proteins with features of the lipoprotein signal sequences among the streptococcal extracellular proteins identified by hydrophilicity blot analysis. Sutcliffe and Harrington [44] recently identified 28 putative lipoprotein genes of GAS using a modified version of the Prosite consensus pattern PS00013 (http://www .expasy.ch/prosite/) of lipoprotein signal sequences,
Four of the proteins they identified (Spy0247, Spy0351, Spy0857, and Spy1792) were not included in our list. We excluded Spy0247 and Spy0351, as well as an- 3 . Titers of specific antibody and bactericidal activity of immune mouse blood. A, The reciprocal titers of serum samples after the third immunizations were determined by ELISA, as described in the text. The mean for serum samples from 4 mice for each protein is titer ‫ע‬ SE presented. B, Direct bactericidal activity. Strain MGAS5005 group A Streptococcus (GAS) were inoculated in 0.15 mL of heparinized blood from a control mouse (sham immunized) or a mouse actively immunized with each protein. The samples were rotated end-over-end at 37؇C for 3 h, and the no. of viable bacteria was determined by plating on blood agar plates. The mean colony for 4 mice in each group is presented. no. ‫ע‬ SE The number on the X-axis is the Spy no. for the protein used in the ELISA (A) or for immunization (B). Statistical analysis was done by 1-tailed unpaired t test, using GraphPad Prism (GraphPad Software). *P ! , vs. control. .05 other protein, Spy1315, because they appear to be integral membrane proteins with several transmembrane domains. Spy0857 has a secretion signal sequence typical of many conventional secreted proteins, and Spy1792 has an LPXTG motif at the carboxyterminus characteristic of cell wall-linked proteins of gram-positive bacteria [45] . Conversely, Spy0163, Spy0457, Spy0778, Spy1094, Spy1592, and Spy2032 were not identified as putative lipoproteins by Sutcliffe and Harrington [44] . Spy0778, Spy1094, Spy1592, and Spy2032 appear to be the binding proteins of 4 putative ABC transporters. These discrepancies demonstrate that several bioinformatic strategies are useful in searches designed to identify proteins with particular characteristics of interest.
Inferred functions of the putative lipoproteins. Sixteen of the 30 genes we identified are part of putative operons that also encode 1 or 2 permeases and an ATP-binding protein.
These lipoproteins appear to be the binding proteins of putative ABC transporters (table 2) that constitute uptake systems for amino acids, peptides, sugars, metal ions, heme, phosphate, or unknown nutrients. The transporters containing Spy0293 [46] and Spy2000 [47] function in uptake of oligopeptides and dipeptides, respectively. Recombinant Spy0453 has been shown to bind Zn 2+ , Cu
2+
, and Fe 3+ [48] . Three putative non-ABC transporter lipoproteins (Spy0457, Spy1882, and Spy2066) have homology with peptidyl-prolyl cis-trans isomerase, acid phospha-tase, and dipeptidase enzymes, respectively. Spy1094 and Spy2007 may contribute to pathogen adhesion to the host. Spy1390 and Spy2037 have regions of homology with a protease maturation protein of Lactococcus lactis [49] .
New GAS vaccine candidates. Active immunization of mice with recombinant Spy0385, Spy1245, Spy1274, Spy1390, and Spy1558 stimulated production of antibodies that significantly inhibited in vitro growth of GAS in blood, as assessed by a commonly used bactericidal activity assay. These 5 proteins are highly conserved among the strains of 6 different M protein serotypes (M1, M3, M5, M12, M18, and M28) for which genome sequence data are available (table 2) . These strains include representatives of opacity factor-negative and opacity factor-positive GAS. All 5 candidate vaccine proteins were reactive with convalescent-phase serum samples obtained from humans with pharyngitis or invasive infections. In addition, with the exception of Spy1245, all of the proteins reacted with serum from mice with experimental soft-tissue infection. It is possible that the lack of specific antibody to Spy1245 in the infected mice was the result of a poor immune response to this protein in this infection model. Alternatively, it is possible that Spy1245 is not expressed or is poorly expressed in these animals. Regardless, the serologic data clearly indicate that Spy1245 is expressed and is antigenic in humans with GAS infection. Studies now under way will assess the ability of these 5 proteins to protect experimentally infected animals against GAS disease.
Spy0385 is the lipoprotein component of an ABC transporter encoded by spy0383-spy0386 that is homologous to a ferrichrome ABC transporter, which suggests that Spy0385 is involved in iron acquisition. Moreover, growth in iron-depleted medium results in up-regulation of transcription of spy0385 [50] . Iron is essential for GAS growth and also regulates expression of virulence factors [51] [52] [53] . Inhibition of iron uptake might be the basis whereby antibodies raised against Spy0385 detrimentally alter the growth of GAS in blood in vitro. Of note, proteins involved in iron acquisition in other human pathogens are under intense investigation as potential therapeutic targets [30] [31] [32] [33] [34] [35] [36] 54] .
Spy1390 is a homologue of the protease maturation protein PrtM of L. lactis [49] . PrtM is essential for the production of active forms of the serine protease PrtP. Of note, immunization of mice with the PrtM homologue of Streptococcus pneumoniae elicits opsonophagocytic antibodies and a protective immune response [55] . The spy1390 gene is possibly in an operon with spy1392 that encodes a putative permease, but no ATP-binding protein gene is present nearby. Spy1558 is a thioredoxin homologue and probably is involved in the repair of oxidative damage to proteins [56] . Spy1274 is a component of a putative amino acid ABC transporter and was the only transporter for amino acid/peptides and sugars in our study that induced antibodies that promote significant bactericidal activity. Spy1245 is part of a putative phosphate transporter, and homologues of this protein have not been reported to be protective antigens in other bacterial pathogens.
In summary, we identified 30 putative lipoproteins of GAS, expressed and purified 16 of these proteins, and identified 5 new GAS vaccine candidate antigens. Further work is under way to determine whether active immunization with these proteins will contribute to protective immunity in relevant animal models of GAS infection. In recent years, genome sequencing, coupled with advances in technology, has permitted development of rapid strategies to identify potential new vaccine candidates in many bacterial pathogens [29, 45, [57] [58] [59] [60] [61] . For example, serologic proteome analysis has been used to identify novel candidate vaccine antigens in GAS [45] , Staphylococcus aureus [57] , and Helicobacter pylori [58] . Reid et al. [45] used bioinformatic methods, combined with gene cloning and protein overexpression, to identify several new vaccine targets in GAS. Genome-wide approaches have resulted in identification of new vaccine molecules in N. meningitidis [29] , S. pneumoniae [60] , and S. aureus [57] . Grifantini et al. [61] recently reported that expression microarray analysis, gene cloning, protein overexpression, and in vitro bactericidal assays could be used successfully to identify vaccine candidates in N. meningitidis. The results of our study support the idea that new vaccine candidate antigens can now be rapidly identified and characterized, thereby adding potential new tools to the goal of developing an efficacious human GAS vaccine. the protein were pooled. The protein was precipitated with (NH 4 ) 2 SO 4 at 70% saturation, pelleted by centrifugation, dialyzed, and loaded onto a -cm Q-sepharose column. 1.5 ϫ 16 Homogeneous protein was obtained by elution with a 100-mL gradient of 0-180 mmol/L NaCl.
Purification of Spy0453. For purification of Spy0453, cell lysate was loaded onto a -cm DEAE-sepharose column, 2.5 ϫ 10 and the column was washed with 50 mL of THCl. (NH 4 ) 2 SO 4 (21 g) was added to 100 mL of the flowthrough pool. The sample was centrifuged at 20,000 g for 10 min, and the supernatant was loaded onto a -cm phenyl sepharose column. The 2.5 ϫ 5 column was washed with 170 mL of 1.5 mol/L (NH 4 ) 2 SO 4 , and the protein was eluted with a 100-mL linear gradient of 1.5-1.0 mol/L (NH 4 ) 2 SO 4 . Fractions containing recombinant Spy0453 were pooled.
Purification of Spy1228. For purification of Spy1228, cell lysate was loaded onto a -cm DEAE-sepharose column, 2.5 ϫ 30 and the protein was eluted with 200 mL of 5 mmol/L NaCl. Fractions containing Spy1228 were pooled. (NH 4 ) 2 SO 4 was added to 90% saturation, and the protein precipitate was removed by centrifugation. The protein in the supernatant was loaded onto a -cm phenyl sepharose column and eluted 1.5 ϫ 10 with 100 mL of 1.5 mol/L (NH 4 ) 2 SO 4 . The eluted protein was dialyzed and loaded onto a -cm DEAE-sepharose col-1.5 ϫ 10 umn, and the protein was eluted with a 60-mL linear gradient of 0-7 mmol/L NaCl. The protein was dialyzed against THCl and concentrated with a Centricon P-22 unit (Millipore).
Purification of Spy1294. For purification of Spy1294, cell lysate was loaded onto a -cm DEAE-sepharose column, 2.5 ϫ 10 the column was washed with 100 mL of 90 mmol/L NaCl, and the fractions containing the protein were pooled. (NH 4 ) 2 SO 4 (15 g) was added to 130 mL of the pool, and the sample was stirred for 10 min and centrifuged. Proteins in the supernatant were precipitated by addition of 45 g of (NH 4 ) 2 SO 4 , pelleted by centrifugation, suspended in a minimum volume of THCl, and loaded onto a -cm phenyl sepharose column. The 1.5 ϫ 10 column was eluted with 1.5 mol/L (NH 4 ) 2 SO 4 , and the fractions containing Spy1294 were pooled.
Purification of Spy1558. For purification of Spy1558, cell lysate was loaded onto a -cm SP-sepharose column.
ϫ 30
The column was washed with 80 mL of THCl and eluted with a 200-mL linear gradient of 0-0.2 mol/L NaCl. Fractions containing the protein were pooled. (NH 4 ) 2 SO 4 was added to the pooled material to a concentration of 1.5 mol/L, and the sample was loaded onto a -cm phenyl sepharose column. The 1.5 ϫ 10 column was washed with 40 mL of 1.5 mol/L (NH 4 ) 2 SO 4 and eluted with an 80-mL gradient of 1.5-0 mol/L (NH 4 ) 2 SO 4 . The pooled protein was dialyzed, and column chromatography with an SP-sepharose column was repeated.
Purification of Spy2000. For purification of Spy2000, cell lysate was loaded onto a -cm DEAE-sepharose column, 2.5 ϫ 30 and the protein was eluted with 200 mL of 90 mmol/L NaCl in THCl. The pooled protein was precipitated with (NH 4 ) 2 SO 4 at a saturation of 70%, pelleted by centrifugation, dialyzed, and loaded onto a -cm SP-sepharose column. The protein 2.5 ϫ 30 was eluted with a 200-mL linear gradient of 0-0.5 mol/L NaCl and pooled.
